Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kevin Richardson

Orthopaedic Surgery of the Spine San Antonio, TX Medical Doctor

NPI 1548465107 CMS profile 161507

2833 Babcock Rd Ste 306, San Antonio, TX 78229

Open in the dashboard

General payments

$90,168

301 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kevin Richardson of San Antonio, TX is reported in the CMS Open Payments database as having received $90,168 across 301 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $24,136 100
2024 General $11,981 65
2023 General $12,418 43
2022 General $15,243 40
2021 General $15,615 19
2020 General $6,051 15
2019 General $4,724 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kevin Richardson
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Kevin Richardson were reported at $24,136. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Kevin Richardson Orthopaedic Surgery of the Spine median Middle half National median
2019 $4,724 $2,106 $337–$18,608 $163
2020 $6,051 $1,213 $156–$15,082 $114
2021 $15,615 $1,834 $271–$15,617 $132
2022 $15,243 $2,015 $320–$17,036 $149
2023 $12,418 $1,925 $336–$14,599 $160
2024 $11,981 $2,110 $341–$12,483 $164
2025 $24,136 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CoreLink, LLC $37,747 44 payments
  2. Zavation LLC $33,257 42 payments
  3. Theragen, Inc. $6,400 1 payment
  4. HD LifeSciences LLC $3,115 2 payments
  5. Zimvie Inc. $1,600 1 payment
  6. Boston Scientific Corporation $1,360 78 payments
  7. Medtronic, Inc. $1,095 21 payments
  8. Globus Medical, Inc. $1,091 25 payments
  9. Abbott Laboratories $1,045 21 payments
  10. Spinal Elements, Inc. $796 9 payments
  11. Other $2,663 57 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $40,253 11 payments
  2. Food and Beverage $14,816 265 payments
  3. Royalty or License $14,597 2 payments
  4. Travel and Lodging $11,283 16 payments
  5. Debt forgiveness $8,000 2 payments
  6. Entertainment $1,120 4 payments
  7. Gift $100 1 payment
Products named General payments · program years 2019–2025
  1. ActaStim-S $6,400 1 payment
  2. Biomet SpinalPak Non-invasive Spine Fusion Stimulator System $1,600 1 payment
  3. Senza Spinal Cord Stimulator $960 17 payments
  4. WaveWriter Alpha Prime 16 $959 69 payments
  5. PAINTEQ $710 21 payments
  6. Medical Device $509 4 payments
  7. SYNCHROMEDII $506 5 payments
  8. Proclaim Family of SCS IPGs $487 8 payments
  9. INTELLIS ADAPTIVESTIM $276 6 payments
  10. Senza Spinal Cord Stimulator $236 5 payments
  11. Other $2,938 73 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

238

Median for Orthopedic Surgery: 203

Drug cost

$5,092

Median for Orthopedic Surgery: $1,433

Branded share of claims

34%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 81 $3,316
Gabapentin Generic 75 $831
Cyclobenzaprine Hcl Generic 33 $646
Methocarbamol Generic 24 $217
Tramadol Hcl Generic 25 $83

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$120,614

Medicare's payments for the services billed

Medicare patients

260

Average age 74

Services billed

650

150 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 36%
Ischemic heart disease 30%
Depression 27%
Chronic kidney disease 23%
Osteoporosis 23%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

301 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record